Seeking Alpha

  Protalix BioTherapeutics, Inc (PLX) - NYSEMKT

PLX vs. ETF Alternatives
Company Description
Protalix BioTherapeutics, Inc. is a biopharmaceutical company engaged in the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system.
Sector: Healthcare
Industry: Biotechnology
Country: United States